{"@id":"https://bioecon.ru/technology/radioligand-therapy/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/radioligand-therapy/","json":"https://en.bioecon.ru/api/v1/technology/radioligand-therapy/index.json"},"id":"radioligand-therapy","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/zero-cow-factory/","https://bioecon.ru/companies/21st-bio/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/anft-association-of-nature-forest-therapy/"]},"maturity":7,"name":"Radioligand Therapy","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Chelator conjugation \u0026 chemistry"},{"n":2,"title":"Targeted radionuclide radiolabeling"},{"n":3,"title":"Microdosimetry and cell-level cytotoxicity"},{"n":4,"title":"Phase clinical validation"}],"summary":"Next-generation precision oncological radiopharmaceuticals conjugating tumor-homing small molecules, peptides, or antibodies with high-linear energy transfer (LET) alpha-emitters (Lead-212, Actinium-225) or beta/Auger emitters (Terbium-161, Lutetium-177), delivering lethal localized DNA double-strand breaks directly into cancer cells.","url":"/technology/radioligand-therapy/","verified":"2026-11-22"}